从胆固醇到葡萄糖:揭示他类药物如何诱导β细胞功能障碍以促进2型糖尿病
The Journal of endocrinology
|July 1, 2025
概括
广泛用于心血管健康的他类药物可能通过损害胰腺β细胞功能增加2型糖尿病的风险. 进一步的研究对于了解和减轻这种风险至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 类药物是预防心血管疾病的主要降脂药物.
- 已知使用他类药物的副作用是新发型2型糖尿病 (T2D) 的风险增加.
- 在他类药物诱导的T2D背后的精确机制仍然不完全理解.
研究的目的:
- 本综述侧重于他类药物对胰腺β细胞功能的有害影响.
- 它旨在阐明他类药物如何导致β细胞功能障碍和死亡.
- 该审查强调了有关他类药物对β细胞影响的知识差距.
主要方法:
- 审查关于他类药物机制的现有文献.
- 对美瓦酸途径在他类药物诱导的T2D中的作用的分析.
- 讨论贝塔细胞基因表达,蛋白质调节和细胞组件.
主要成果:
- 类他类药物抑制了美酸盐路径,影响胆固醇和非胆固醇的合成.
- 有关的是异常的基因/蛋白质表达和β细胞成分 (线粒体,通道) 的失调.
- 斯坦丁对β细胞胆固醇代谢和性别差异的影响还未得到充分研究.
结论:
- 类药物可能会对胰腺β细胞功能产生负面影响,可能导致T2D.
- 了解这些机制对于管理他类药物相关的糖尿病风险至关重要.
- 迫切需要对β细胞胆固醇代谢和性别影响进行进一步的研究.
相关概念视频
Carbohydrate Metabolism
11.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.8K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
309
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
309
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
884
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
884


